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Abstract:
The current evidence-base for the psychological treatment of distressing 
voices indicates the need for further clinical development. The Maastricht 
approach (also known as Making Sense of Voices) is popular within 
sections of the Hearing Voices Movement, but its clinical effectiveness 
has not been systematically evaluated.  The aim of the approach is to 
develop a better understanding of the role of the voice, in part through 
opening a dialogue between the voice hearer and the voice. The current 
study was a (N=15) case series adopting a concurrent multiple baseline 
design. The Maastricht approach was offered for up to 9-months. The 
main outcome, weekly voice-related distress ratings, was not statistically 
significant during intervention or follow-up, although the effect size was 
in the moderate range. The PSYRATS Hallucination scale was associated 
with a large effect size both at the end of treatment, and after a 3-
month follow-up period, although again the effect did not reach 
statistical significance. The results suggest further evaluation of the 
approach is warranted. However, given the large variance in individual 
participant outcome, it may be that a better understanding of response 
profiles is required before conducting a definitive randomised controlled 
trial. 
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Abstract
The current evidence-base for the psychological treatment of distressing voices indicates the 
need for further clinical development. The Maastricht approach (also known as Making Sense 
of Voices) is popular within sections of the Hearing Voices Movement, but its clinical 
effectiveness has not been systematically evaluated.  The aim of the approach is to develop a 
better understanding of the role of the voice, in part through opening a dialogue between the 
voice hearer and the voice. The current study was a (N=15) case series adopting a concurrent 
multiple baseline design. The Maastricht approach was offered for up to 9-months. The main 
outcome, weekly voice-related distress ratings, was not statistically significant during 
intervention or follow-up, although the effect size was in the moderate range. The PSYRATS 
Hallucination scale was associated with a large effect size both at the end of treatment, and 
after a 3-month follow-up period, although again the effect did not reach statistical 
significance. The results suggest further evaluation of the approach is warranted. However, 
given the large variance in individual participant outcome, it may be that a better 
understanding of response profiles is required before conducting a definitive randomised 
controlled trial.
Keywords: auditory hallucinations, psychotherapy, Hearing Voices Movement, Experience 
Focussed Counselling, voice dialogue, talking with voices, Making Sense of Voices.
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Introduction
The prevalence of hallucinatory experience within the general population has been estimated 
at 6% (Linscott & van Os, 2013). Within the psychiatric system, voice-hearing experiences 
are reported to have a lifetime prevalence of around 64 – 80 % in people diagnosed with 
schizophrenia spectrum disorders (McCarthy-Jones et al., 2017). Voice hearing is also 
associated with a range of other mental health problems, including bipolar disorder, 
depression, personality disorders, posttraumatic stress disorder (PTSD) and dissociative 
identity disorder, as well as with individuals without a history of mental health problems 
(Baumeister, Sedgwick, Howes & Peters, 2017). 
The dominant perspective within which voices are understood remains the bio-
medical model, in which voice hearing is perceived as a symptom of an underlying illness, 
such as schizophrenia. Within this model, the content of the voices is considered of limited 
relevance, and the primary treatment strategy is to remove, or to reduce, the voice hearing 
experience via pharmaceutical intervention. However, since the conception of this approach 
in the 1950s, there has been negligible development in the effectiveness of anti-psychotic 
medication (Jones et al., 2006; Leucht et al., 2017). There is also an increased awareness of 
the dangers associated with the long-term prophylactic use of these drugs including reduced 
cortical volume and a potential for dopamine supersensitivity (Murray et al., 2016). Also, it is 
now clear that many people diagnosed with schizophrenia recover without the use of 
neuroleptic medication (Harrow, & Faull, 2014). Furthermore, the effectiveness of 
neuroleptics has been shown to be reduced in individuals with a history of trauma (Hassan & 
De Luca, 2015), a finding that is particularly relevant to voice hearing, which is associated 
with a high level of exposure to traumatic events (Varese et al. 2012).
Recent years have seen cognitive behavioural therapy (CBT) become an established 
treatment for schizophrenia (NICE, 2009). However, a recent meta-analysis of individual 
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formulation-based CBT for schizophrenia showed that the outcome for voice hearing was a 
small to moderate effect size (van der Gaag, Valmaggia & Smit, 2014). There is, therefore, 
considerable room for improvement when working with this phenomenon. 
There has also been a recent increase in the awareness of the high prevalence of 
traumatic life events experienced by people who have been diagnosed with schizophrenia 
(e.g. Matheson, Shepherd, Pinchbeck, Laurens & Carr, 2013). The prevalence of PTSD has 
been estimated to be approximately 13% within this group (Achim et al., 2011). This co-
morbid presentation is associated with a poor prognosis and increased use of healthcare 
(Switzer et al., 1999). Recent literature highlights the link between childhood sexual abuse 
and hearing voices (McCarthy-Jones, 2011), although the theoretical understanding of this 
relationship remains in its infancy. Within the CBT for voices framework, most attention is 
paid to the beliefs that an individual has about their voice hearing experience. However, it has 
been noted that the relationship a voice-hearer has with their voice(s) may be based on the 
same underlying mechanisms that influence that individuals relationships within other people 
in their lives (Paulik, 2012). Therefore, in an effort to improve outcomes, recent 
developments within the field have put the relationship between a voice hearer and their 
voice at the forefront (Hayward, Berry, McCarthy-Jones, Strauss &Thomas, 2013; Craig et 
al., 2018). It is of note that these new approaches encourage assertive communication from 
the voice hearer to their voice(s).
Clinicians often refer to a voice being linked to a life event, but that the content and 
communication has ‘evolved’ beyond the specific event which is considered to be the trigger. 
The premise that voices ‘arrive’ in peoples’ lives as part of a meaningful reaction to 
unresolved traumatic life events, and that voice content is relevant and should be engaged 
with (including the use of active ‘Voice Dialoguing’), underlies an approach put forward by 
Marius Romme and Sandra Escher (2000) often called the ‘Maastricht Approach.’ Devised in 
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collaboration with voice hearers, the framework has become established within the 
international Hearing Voices Movement (Corstens, Longden, McCarthy-Jones, Waddingham 
& Neil, 2014), although it has largely remained beyond academic investigation and outside of 
mainstream clinical services. Defining features of the approach are its emphasis on 
depathologising the voice hearing experience, its transdiagnostic scope, and the value it 
places on exploring the content, potential meaning and intentions of the voices (Corstens et 
al., 2014; Longden, 2017).
The Maastricht approach is also referred to as ‘Making Sense of Voices’ (MsV; 
Romme & Escher, 2000) and Experience Focussed Counselling (Schnackenberg, Fleming & 
Martin, 2017; Schnackenberg, Fleming & Martin, 2018b; Schnackenberg, Walker, Fleming 
& Martin, 2018a). The version adopted within the current study consists of three phases of 
work. First, an engagement phase and a discussion of basic coping strategies that may help 
with distressing voices. Second, an assessment phase occurs in which the voice content and 
characteristics are collaboratively explored using a form of psychological formulation known 
as ‘the construct’. The third phase involves the development of a new voice-hearer led 
understanding of the voices, possibly in relation to life events. Subsequent work, based on the 
new understanding, is aimed at supporting the voice hearer to feel less threatened by the 
voice hearing experience and to adopt a less submissive position. The approach also includes 
‘Voice Dialoguing’ techniques in which the voice hearer is encouraged to engage in an active 
dialogue with their voices. The aim is to resolve conflict and develop a new understanding of 
the meaning behind the voice content (Corstens, Longden & May, 2012).
The MsV approach is highly regarded within the service user movement, and offers a 
new perspective for helping individuals come to terms with voice hearing experiences who 
may not have found the support they need within mainstream psychiatric services (Longden, 
Corstens & Dillon, 2013). There are also indications that the MsV approach is applicable 
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transdiagnostically (Schnackenberg et al., 2018a) and may be considered an approach that is 
sensitive to a trauma history (Schnackenberg et al., 2018b). However, the current evidence-
base for the MsV approach is limited to a small pilot randomised controlled trial 
(Schnackenberg et al., 2017), assessment of specific elements of the approach (Corstens & 
Longden, 2013) and a collection of personal testimonies (Romme, Escher, Dillon, Corstens & 
Morris, 2009). Given the widespread use of the MsV approach it is important that it receives 
further evaluation. 
The current study aimed to evaluate outcomes of the MsV approach with a particular 
focus on using Voice Dialoguing techniques. The main outcome was voice-related distress. 
However, a number of secondary outcomes were included in order to gather information on 
potential mechanisms that may be associated with the intervention and worthy of further 
investigation in future research. The case series involved a randomised period of baseline, a 
9-month period of intervention and a 3-month follow-up. Although the MsV approach was 
not developed with a fixed number of sessions in mind, we offered a maximum of 20 sessions 
within 9-months so as to be able to make broad comparisons with the outcomes of other 
clinical trials in the field.
Method
Participants
To be considered for the case series, potential participants had to report currently distressing 
voices as determined by a rating of 2 or above on the ‘Intensity of Distress’ item on the 
Psychotic Symptoms Rating Scale for Auditory Hallucinations (Haddock, McCarron, Tarrier 
& Faragher, 1999) scale. There were no other restrictions on the entry criteria regarding 
diagnosis, although participants had to have had recorded contact with mental health services 
at the point of recruitment, be aged 18-65, and have had no significant history of organic, or 
Page 5 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
6
drug/alcohol factors implicated in the aetiology of psychotic symptoms. They also needed to 
be able to speak English and have a fixed abode. All participants gave written consent to take 
part in the study.
Design
A concurrent multiple baseline design was used. Participants were randomly allocated to 
receive either a 4, 5, 6, 7 or 8-week wait duration (3 in each condition), prior to the 
intervention starting. Having a varied length of baseline allowed for the differentiation 
between the time effects during the baseline phase and the experimental effects during the 
intervention phase. The intervention consisted of a maximum of 20 individual sessions to be 
conducted within a 9-month period starting at the end of the waitlist. Assessments on the 
primary outcome (a measure of voice-related distress) were conducted on a weekly basis. 
Secondary assessments were conducted on up to five occasions; prior to the waitlist period 
starting (baseline), at the end of wait list period (pre-treatment), at the end of the construct 
phase of intervention (post-construct), at the end of the intervention (post-treatment) and at a 
3-month follow-up from the end of the intervention. The post-construct assessment was only 
conducted with the participants who progressed to this stage of the process and therefore this 
data was not included in the main statistical analyses. 
The study was given NHS ethical approval by the South Central Berkshire B 
(15/SC/0013) and the protocol was registered (ISRCTN5437085).
The Making Sense of Voices Approach (Romme & Escher, 2000)
Assessment and construct:
After engagement, the first phase of the approach involves conducting the Maastricht Hearing 
Voices Interview. For many voice hearers, this forms part of the intervention as the 
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conversation can challenge cognitive avoidance of the topic. The interview leads to the 
development of the ‘construct’, a collaborative, voice-hearer led process within which an 
individual’s personal history is explored in relation to the formation and content of the voices 
they hear. Voice hearers are offered an opportunity to explore alternative approaches to 
understanding the assumed original mechanisms of their voices and efforts are made to identify 
the personal problems or functions that the voices may represent. 
Intervention: 
Communication with voices was guided by the assumption that voice hearing can originate 
from stressful life events and that the voices may be functioning so as to protect personal 
vulnerabilities. Based on the construct developed in the first phase the accompanying person 
(in this study a trained mental health professional) works towards opening a dialogue with the 
voice. An open, exploratory approach as to what it may be that the voice is trying to 
communicate is adopted. It is not uncommon for a voice to express itself through exaggerations 
and metaphors prior to a change in the relationship with the voice hearer (Moskowitz, 
Mosquera & Longden, 2017). The dialogue may be either indirect (in that the voice hearer first 
listens to what the voice says and then repeats it) or direct (in which case the voice hearer 
communicates what the voice says in real time). The aim is to reconstruct the relationship with 
the voices to become more peaceful and equitable. Voices may transpire to be ‘allies’ of the 
voice hearer during the process, and reveal a protective function, such as the need to draw 
attention to unresolved current and past conflicts (see Corstens, Longden & May, 2012, for 
further details).
The MsV intervention (comprising of the assessment, construct and intervention phases) was 
delivered individually by one of four mental health workers (two clinical psychologists and 
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two counselling psychologists), who received training and regular supervision from two of 
the authors (JS and DC). Training comprised of six days from JS and one person with lived 
experience of voice hearing and two days from DC along with two people with lived 
experience of voice hearing.
Outcome measures
Main Outcome
Hallucination Change Scale (HCS, Hoffmann et al., 2003).  The primary outcome, HCS, was 
based on weekly ratings of the distress associated with voice hearing and is hereafeter referred 
to as ‘voice-related distress’. Each participant generated a narrative description of their voices 
for the one-week period prior to initiation of the first assessment, and rated the associated level 
of distress. This rating then became the baseline or ‘0’ rating for the purpose of calibrating 
future ratings. The weekly voice-related distress ratings were scored in subsequent assessments 
by requesting the voice-hearer to generate a new narrative description of their voices. 
Subsequent severity scores ranged from +10, corresponding to a maximum possible decrease 
in voice-related distress, to a score of -10, corresponding to a maximum possible increase in 
voice-related distress. Ratings corresponded to the average experience over the previous week, 
and were always rated with reference to the original zero calibration score. Data was collected 
on a weekly basis during the wait and intervention phase, and on a monthly basis during the 3-
month follow-up phase.
Secondary Outcomes
Psychotic Symptoms Rating Scale for Auditory Hallucinations (PSYRATS (AH); 
Haddock et al., 1999). 11 items completed on the basis of a clinical interview enabling 
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analysis in relation to voice distress specifically, as well as a wider range of voice 
characteristics.
Beliefs about Voices Scale (BAVQ-R; Chadwick, Lees & Birchwood, 2000). A 35-
item self-report measure of the appraisals made in relation to the voice hearing experience.
DAIMON scale (Perona-Garcelan et al., 2015). A 28-item self-report measure 
assessing how an individual relates to their voice hearing experience. Two of the five 
subscales (the person’s relationship with his/her voices and the voices’ relationship with the 
person) are reported here.
Generalised Anxiety Disorder (GAD7; Spitzer, Kroenke, Williams & Lowe, 2006). A 
7-item self-report measure, each describing anxiety symptoms, and endorsed 
on the basis of frequency over the previous two weeks.
Physical Health Questionnaire (PHQ9; Kroenke, Spitzer & Williams, 2001). A 9-
item self-report measure of depression covering all nine of the DSM-IV criteria and based on 
assessment of the frequency over the previous two weeks.
Dissociative Experience Scale (DES; Bernstein & Putman, 1986). A 28-item self-report 
measure of a wide variety of types of dissociation, including both problematic dissociative 
experiences and normal dissociative experiences (e.g. day-dreaming). Only the DES-Taxon 8-
item subscale is reported in this study which measures a discontinuous, pathological class of 
dissociation. 
Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; Tennant et al., 2006). A 14-
item self-report questionnaire which includes both hedonic and eudaimonic 
features rated on a five-point scale.
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Self-Compassion Scale- Short form (SCS; Raes, Pommier, Neff & Van Gucht, 2011). 
A brief form of the original 26-item scale which was designed to measure self-judgement, 
self-kindness and self-criticism. 
Statistical analysis 
The primary endpoint was analysed using linear mixed models.  The fixed effects (predictors) 
included a linear time variable where 1= the first weekly voice-related distress rating on 
treatment, dummy indicators for treatment and follow up phases which contrast to baseline, 
and two time within phase variables, one for the treatment phase and one for the follow-up 
phase (0 was given as the last timepoint in the phase to allow the model to easily produce 
comparisons of interest at the end of the phases) (cf. Vlaeyen, De Jong, Geilen, Heuts, & Van 
Breukelen, 2001). The models also included random intercept for subject and used an 
ARMA(1,1) covariance structure for the repeated time within subject. These account for the 
between subject variation and within subject variation. Due to the small sample size the 
Kenwood Roger degrees of freedom adjustment was used. Random slopes were also 
investigated however these often lead to issues with the models or reduced fit and therefore 
were not included.  An initial model was fitted to only test a linear time effect.  After this a 
full model containing all predictors as described above was fitted and then the time within 
phase predictors were assessed and removed in a backwards stepwise fashion if they were not 
significant. If the main linear effect of time was not significant at this stage it was removed. 
The random effects were included in all models.  Cohen’s d was derived as an effect size of 
the treatment and follow-up phases compared to baseline. The difference between phase of 
interest and the baseline (wait weeks) phase was taken from the relevant parameter estimates 
from the fixed part of the model. The denominator used was the square root (between subject 
variance + (within subject variance/average number of measurements per phase)). The 
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between subject variance is obtained from the variance of the random intercept and the within 
subject variance uses the residual variance from the model. A sensitivity analysis was 
performed where the time variable was defined as 1 being the first weekly voice related 
distress rating for an individual.
The secondary outcomes were analysed using linear mixed models. A categorical 
time variable representing the four assessment visits (i.e. not including the post-construct 
assessment) was fitted as a fixed effect.  An unstructured covariance structure was used to 
account for the repeated assessments within a subject. Kenwood Roger degrees of freedom 
was also used. Standardized measures of effect size (Glass’ delta) were derived for the 
comparison of the post-treatment visit and the pre-treatment visit, and for the comparison of 
the follow-up visit and the pre-treatment visit using the relevant adjusted difference divided 
by the control s.d. (pre-treatment). Comparisons between start of baseline and pre-treatment 
were also made. The post-construct assessment was not included in the main analysis but was 
included within the relevant participants’ graphs based on the weekly voice distress ratings 
which can be observed in Figure 1.
All available data was used in the analyses and all missing data was assumed to be 
missing at random. The analyses using restricted maximum likelihood are robust when 
outcomes are missing at random. However, two participants stopped hearing voices during 
the intervention and therefore some assessments were not relevant (BAVQ-R and DAIMON) 
and were initially recorded as missing, sensitivity analyses were performed where these 
missing values were imputed as the ‘best case’ for these assessments (BAVQr Malevolence, 
BAVQr Omnipotence and DAIMON Voice addresses person were inputted as zero, BAVQr 
Benevolence was inputed as 18 and DAIMON Person address Voice was inputted as 40). The 
statistical analyses were performed using SAS 9.4. 
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Results
Fifteen participants were recruited (see Table 1 for baseline characteristics), with three 
participants randomised to each of the five wait durations. All participants were being 
prescribed anti-psychotic medication at the time of their initial screening assessment.
----------------
Table 1 here
----------------
Eleven participants remained fully engaged throughout the study and received 
between 18 and 20 individual sessions within the 9-month period allocated for the MsV 
intervention. Four participants disengaged from the intervention before the end of treatment, 
although one of these had received 15 sessions and remained engaged with the wider study 
and provided some follow-up data. Three participants did not complete the assessments for 
the secondary outcomes at post-treatment or follow-up. One of these received 5 sessions 
before they moved out of the NHS Trust within which the study was being conducted. Two 
participants stated that they did not find the approach beneficial and requested that they no 
longer be contacted after the point at which they withdrew from the intervention (5 sessions 
for one and 6 sessions for the other). Overall 28.13% of the weekly voice-related distress 
ratings were missing. There were no serious adverse events associated with the intervention 
for any of the participants during the study.
The individual weekly voice-related distress ratings of the 15 participants during the 
different phases of the study are shown in Figure 1.
----------------
Figure 1 here
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----------------
The initial mixed regression analysis fitting time showed a statistically significant linear 
effect of time (parameter estimate 0.066, t=2.11, p=0.049). Once all predictors were entered, 
time within treatment phase and time within follow-up phase were not statistically significant 
and were removed from the model in a stepwise fashion. After these were removed, the linear 
effect of time was also not statistically significant (parameter estimate 0.058 t=1.51, p=0.14) 
and was also removed from the model. Table 2 presents the final results from the linear 
mixed regression analysis of the weekly hallucination change scores. The intervention (MsV) 
did not have a statistically significant effect on the weekly voice-related distress ratings, 
either during the intervention (as compared to baseline (wait weeks)) or follow-up phase (as 
compared to baseline (wait weeks)). However, the effect sizes were in the moderate range.  
The individual profile plots and inspection of the conditional residuals from the model gave 
some indication that participants seemed to broadly fit into either a group who responded 
well to the approach or to a group who did not respond at all. Therefore, some caution needs 
to be taken in the interpretation of the results. The sensitivity analysis yielded similar 
conclusions for the final model. Figures 2a and 2b show the observed means and the 
predicted means from the analysis respectively. 
----------------
Table 2 here
----------------
----------------
Figure 2a here
----------------
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----------------
Figure 2b here (currently a pdf)
----------------
Note that for figures 2a and 2b week1 is the first intervention session for a participant. 
Table 3 presents the post-treatment and follow-up data for all secondary outcomes. With the 
exception of the self-compassion scale and BAVQ-R omnipotence scale at follow-up, no 
outcomes were associated with a statistically significant difference from pre-treatment. 
However, there were large effect sizes for PSYRATS both at the post-treatment and follow-
up compared with pre-treatment, whilst the BAVQ-R malevolence and omnipotence scores 
indicated a moderate effect at post-treatment and a large effect at follow-up. It must be noted 
that for some endpoints the variability increased for post-treatment and follow-up timepoints 
compared to baseline and pre-treatment, this is particularly evident in the PSYRATS scores. 
Note that the standardised effect size presented uses pre-treatment s.d as its denominator. 
There were also no observed statistically significant differences between pre-treatment and 
start of baseline in any of the secondary measures. The results of the sensitivity analyses 
showed moderate effect sizes for all BAVQ-r subscales at end of intervention (Malevolence 
=0.57, Benevolence =0.52, Omnipotence =0.53) and at follow-up for Benevolence (0.65), 
and large effects sizes for Malevolence (0.77) and Omnipotence (1.19) at follow-up. The 
DAIMON Voice address Person results were broadly similar to the main analysis and the 
DAIMON Person address voices showed small effect sizes. However as per the main analysis 
only BAVQ-R Omnipotence and Self compassion scale showed statistically significant 
differences from pre-treatment at follow-up. 
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----------------
Table 3 here
----------------
Discussion
The intervention was viable to deliver within a mainstream clinical NHS setting. Most of the 
participants maintained engagement throughout the full 9-month intervention phase which 
suggests acceptability from both voice hearers and staff. Given that directly engaging with a 
voice through dialogue may induce clinical concern within some mental health workers, it is 
important to note that there were no adverse events associated with the intervention. 
Results based on the main outcome, the weekly voice-related distress ratings, 
indicated that the reduction in distress reported by voice hearers throughout the intervention 
or follow-up phase was not statistically significant. The small sample size will have limited 
the opportunity for statistical significance, and it is of note that the effect size of 0.38 at post-
treatment and 0.56 at follow-up are indicative of the potential for the intervention to provide 
clinically meaningful change. In fact, these effect sizes are similar to those reported for 
individual CBT for voices (van der Gaag et al., 2014). It is also of interest that the effect size 
for MsV was larger at follow-up than at post- treatment. Anecdotally, it was observed that 
several participants struggled to keep a meaningful frame of reference within the weekly 
change scores and this is likely to have reduced the reliability of this outcome.
With respect to the secondary outcome measures, there were large effect sizes on the 
PSYRATS Hallucination scale both at post-treatment and at follow-up, although again these 
did not reach statistical significance. Two of the outcome measures (self-compassion and 
BAVQ-R – omnipotence) did produce statistically significant differences at follow-up 
compared to pre-treatment. However, these results are to be treated with caution given the 
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number of multiple tests. All but three of the outcome measures (BAVQ-R –benevolence 
subscale, BAVQ-R –Malevolence subscale and DAIMON Person address voices) were 
associated with a larger effect size at follow-up when compared to post- treatment. 
The large effect sizes for the voice related outcome measures, and the trend towards 
an increased effect at follow-up suggests that the MsV approach warrants further 
investigation. In part this will be done via a qualitative analysis of interviews conducted with 
the participants of the current case series (in preparation). However, a future study will 
require a parallel control condition, in order to account for the variety of factors that are not 
specifically associated with the intervention, but that may have impacted on the outcomes of 
the current study.
Our outcome data indicated a wide variety of responses across the participants. This 
result is consistent with the anecdotal feedback from the mental health workers in this study 
who often commented on their experience of the participants varying in their engagement 
with the Voice Dialoguing component of the intervention. It may be that this ‘ingredient’ is 
an important part of this approach and that, prior to larger scale evaluation, efforts should be 
made to establish who is most likely to benefit. One aspect of voice hearing that is likely to 
be of interest in this respect is the extent to which the voice hearer dissociates whilst 
communicating with their voices, which may be linked to the extent to which the voice is 
experienced as a disconnected ‘other’ with whom a dialogue can be initiated (Moskowitz, 
Mosquera & Longden, 2017). It is also worth noting that whilst the MsV approach is not 
limited to any diagnostic category, although the majority of the current sample were 
diagnosed with a psychotic disorder. This may have had an impact on our outcomes through 
the impact of long-term use of neuroleptics (Murray et al., 2016).
Acknowledgements
Page 16 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
17
We would like to thank the other contributors to this research, both voice hearers and non 
voice-hearers. Specifically, Suzanne Engelen as one of our trainers in the MsV approach, 
Annie Beyer, Rachel Manser, Tim Walker, Ffion Jones, Megan Kerr and Kathy Greenwood. 
We would also like to thank the fifteen voice hearers who participated in the study, along 
with the staff of Berkshire Healthcare NHS Foundation Trust who facilitated the project.
Declaration of Interest Statement
Three authors (DC, EL & JS) have received financial payments for delivering teaching on the 
MsV approach. There are no other reported conflicts of interest. 
References
Achim, A.M., Maziade, M., Raymond, E., Olivier, D., Mérette, C & Roy, M. (2011). How 
prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on 
a significant association. Schizophrenia Bulletin, 37, 811–21.
Baumeister, D., Sedgwick, O., Howes, O. & Peters, E. (2017). Auditory verbal hallucinations
and continuum models of psychosis: A systematic review of the healthy voice-hearer 
literature. Clinical Psychology Review, 51, 125-141.
Bernstein, E.M. & Putnam, F.W. (1986). Development, reliability, and validity of a
dissociation scale. Journal of Nervous and Mental Disease, 174, 727–35. 
Chadwick, P., Lees, S. & Birchwood, M. (2000). The revised Beliefs About Voices
Questionnaire (BAVQ-R). British Journal of Psychiatry, 177, 229–232.
Corstens, D., Longden, E. & May, R. (2012). Talking with voices: exploring what is
expressed by the voices people hear. Psychosis: Psychological, Social and Integrative 
Approaches, 4, 95 – 104.
Corstens, D. & Longden, E. (2013). The origin of voices: links between life history and voice
Page 17 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
18
hearing in a survey of 100 cases. Psychosis: Psychological, Social and Integrative 
Approaches, 5, 270 – 285.
Corstens, D., Longden, E., McCarthy-Jones, S., Waddingham, R. & Neil, T. (2014). 
Emerging perspectives from the Hearing Voices Movement: implications for research 
and practice. Schizophrenia Bulletin, 40, S285-294.
Craig, T.K.J., Rus-Calafell, M., Ward. T,, Leff, J.P., Huckvale, M., Howarth, E., … Garety,
P.A. (2018). AVATAR therapy for auditory verbal hallucinations in people with 
psychosis: a single-blind, randomised controlled trial. The Lancet Psychiatry, 5, 31-
40.
Haddock, G., McCarron, J., Tarrier, N. & Faragher, E.B. (1999). Scales to measure
dimensions of hallucinations and delusions: the psychotic symptom rating scales 
(PSYRATS). Psychological Medicine, 29, 879–89.
Hassan, A.N. & De Luca, V. (2015). The effect of lifetime adversities on resistance to
antipsychotic treatment in schizophrenia patients. Schizophrenia Research, 161, 496-
500.
Harrow, M., Jobe, T.H. & Faull, R.N. (2014). Does treatment of schizophrenia with
antipsychotic medication eliminate or reduce psychosis; a 20-year follow-up study. 
Psychological Medicine, 44, 3007-3016.
Hayward, M., Berry, K., McCarthy-Jones, S., Strauss, C. and Thomas, N. (2013).
Beyond the omnipotence of voices: further developing a relational approach to
auditory hallucinations. Psychosis: Psychological, Social and Integrative Approaches, 
6, 242-252.
Hoffman, R.E., Hawkins, K.A., Gueorguieva, R., Boutros, N.N., Rachid, F., Carroll, K. &
Page 18 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
19
Krystal, J.H. (2003). Transcranial magnetic stimulation of left temporoparietal cortex 
and medication-resistant auditory hallucinations. Archives of General Psychiatry, 60, 
49–56.
Jones, P.B., Barnes, T.R., Davies, L., Dunn, G., Lloyd, H. & Hayhurst, K.P., … Lewis, S. 
(2006). Randomised controlled trial of effect on quality of life of second- vs first 
generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest 
Antipsychotic drugs in Schizophrenia Study (CUtLASS 1). Archives of General 
Psychiatry, 63, 1079–87.
Kroenke, K., Spitzer, R.L. & Williams, J.B. (2001). The PHQ-9: validity of a brief
depression severity measure. Journal of General Internal Medicine, 16, 606-613.
Longden, E. (2017). Listening to the voices people hear: auditory hallucinations beyond a
diagnostic framework. Journal of Humanistic Psychology, 57, 573-601.
Longden, E., Corstens, D. & Dillon, J. (2013). Recovery, discovery and revolution: the work
of Intervoice and the hearing voices movement. In Madness Contested: Power and 
Practice (ed. S Coles, S Keenan, B Diamond): 161–80. PCCS.
Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., … Davis, J. M.
(2017). Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute 
Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of 
Efficacy Predictors. American Journal of Psychiatry, 174, 927 – 942. 
Linscott R.J. & van Os J. (2013). An updated and conservative systematic review and meta-
analysis of epidemiological evidence on psychotic experiences in children and adults: 
On the pathway from proneness to persistence to dimensional expression across 
mental disorders. Psychological Medicine, 43, 1133–1149.
Matheson, S.L., Shepherd, A.M., Pinchbeck, R.M., Laurens, K.R. & Carr, V.J. (2013).
Page 19 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
20
Childhood adversity in schizophrenia: a systematic meta-analysis. Psychological 
Medicine, 43, 225-238. 
McCarthy-Jones, S. (2011). Voices from the storm: a critical review of quantitative studies of
auditory verbal hallucinations and childhood sexual abuse. Clinical Psychology 
Review, 31, 983-992.
McCarthy-Jones, S., Smailes, D., Corvin, A., Gill, M., Morris, D., Dinan, T., … Dudley, R.
(2017). Occurrence and co-occurrence of hallucinations by modality in schizophrenia-
spectrum disorders. Psychiatry Research, 252, 154-160.
Moskowitz, A., Mosquera, D., & Longden, E. (2017). Auditory verbal hallucinations and the
differential diagnosis of psychotic and dissociative disorders: Historical, empirical and 
clinical perspectives. European Journal of Trauma & Dissociation, 1, 37-46.
Murray, R.M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., … Taylor,
D. (2016). Should psychiatrists be more cautious about the long-term prophylactic use 
of antipsychotics? British Journal of Psychiatry, 209, 361-365.
NICE. Schizophrenia; Full National Clinical Guideline on Core Interventions in Primary and
Secondary Care. London: Gaskell Press; 2009. Updated guideline.
Paulik, G. (2012). The Role of Social Schema in the Experience of Auditory Hallucinations:
A Systematic Review and a Proposal for the Inclusion of Social Schema in a 
Cognitive Behavioural Model of Voice Hearing. Clinical Psychology and 
Psychotherapy, 19, 459-472.
Perona-Garcelánab, S., Escudero-Péreza, S., Barros-Albarrána, M.D., León-Palaciosa, M.G.,
Úbeda-Gómeza, J. García-Montesf, G.M., … Pérez-Álvarezg, M. (2015). Reliability 
and validity of a new scale for measuring relationships with voices: The DAIMON 
scale. Psychosis: Psychological, Social and Integrative Approaches, 7, 312-323.
Raes, F., Pommier, E., Neff, K. D., & Van Gucht, D. (2011). Construction and factorial
Page 20 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
21
validation of a short form of the Self-Compassion Scale. Clinical Psychology & 
Psychotherapy, 18, 250-255.
Romme, M. & Escher, S. (2000). Making Sense of Voices. London: Mind.
Romme, M., Escher, S., Dillon, J., Corstens, D. & Morris, M. (2009). Living with Voices. 50
Stories of Recovery. Ross-on-Wye: PCCS Books
Schnackenberg, J. K., Fleming, M. & Martin, C. (2017). A randomised controlled pilot study
of experience focussed counselling with voice hearers. Psychosis: Psychological, 
Social and Integrative Approaches, 9, 12–24.
Schnackenberg, J., Fleming, M., Walker, H. & Martin, C. R. (2018a). Experience Focussed
Counselling with Voice Hearers: Towards a Trans-diagnostic Key to Understanding 
Past and Current Distress – A Thematic Enquiry. Community Mental Health Journal. 
Advance online publication. doi: 10.1007/s10597-018-0280-6.
Schnackenberg, J., Fleming, M. & Martin, C. R. (2018b). Experience Focussed Counselling
with Voice Hearers as a Trauma-sensitive Approach. Results of a Qualitative Enquiry. 
Community Mental Health Journal. Advance online publication. doi: 
10.1007/s10597-018-0294-0.
Spitzer, R.L., Kroenke, K., Williams, J.B. & Löwe B. (2006).A brief measure for assessing
   generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 22, 1092-
1097.
Switzer, G.E., Dew, M.A., Thompson, K., Goycoolea, J.M., Derricott, T. & Mullins, S.D.  
   (1999). Posttraumatic stress disorder and service utilization among urban mental   
   health center clients. Journal of Traumatic Stress, 12, 25–39.
Tennant, R., Hiller, L., Fishwick, R., Platt, S., Joseph, S., Weich, S., ... Stewart-Brown, S.
(2007). The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): 
development and UK validation.  Health & Quality of Life Outcomes, 27, 5-63. 
Page 21 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
22
van der Gaag M, Valmaggia LR, Smit F. (2014). The effects of individually tailored
formulation-based cognitive behavioural therapy in auditory hallucinations and 
delusions: a meta-analysis. Schizophrenia Research, 156, 30–7.
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., … Bentall, 
R. (2012). Childhood trauma increases the risk of psychosis: a meta-analysis of 
patient-control, prospective- and cross sectional cohort studies. Schizophrenia 
Bulletin, 38, 661-71.
Vlaeyen, J.W.S., de Jong, J., Geilen, M., Heuts, P.H.T.G. & van Breukelen, G. (2001).
Graded exposure in vivo in the treatment of pain-related fear: A replicated single-case 
experimental design in four patients with chronic low back pain. Behaviour Research 
and Therapy, 39, 151-166.
Page 22 of 29
URL: http:/mc.manuscriptcentral.com/rpsy
Psychosis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Table 1. Baseline characteristics of the sample 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 n=15 
Demographics  
    Mean age in years (SD) 46.4 (10.7) 
    Male (%) 46.7 
    White (%) 80.0 
    Age left formal education (SD) 18.2 (2.5) 
    Currently Employed (%) 
 
33.3 
Primary Diagnosis  
    Schizophrenia 7 
    Schizoaffective disorder 2 
    Psychosis NOS 
    Emotionally Unstable Personality    
          Disorder 
3 
2 
 
    Depression 1 
  
Psychiatric history  
    Prior psychiatric   
    Hospitalization (%) 
73.3 
    Mean number of prior   
    Admissions (SD) 
6.9 (9.1) 
    Mean age at first contact 
    with mental health services (SD) 
 
Chlorpromazine-equivalent dose of antipsychotic 
drug (mg/day) (SD) 
27.1 (12.2) 
 
 
 
517 (309) 
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Table 2: Results of mixed regression analysis for weekly Voice Related Distress Ratings 
 
Parameter 
 
β 
 
Std. error 
 
df 
 
t 
 
 
p 
Effect size 
Cohen’s d* 
 
Intercept 
Intervention 
Follow-up 
 
 
1.41 
0.80 
1.60 
 
0.94 
0.65 
1.04 
 
22.1 
305.2 
224.6 
 
1.50 
1.24 
1.54 
 
0.15 
0.22 
0.13 
 
 
0.38 
0.56 
*Effect size Cohen’s D=effect/s.d. derived from variance of the random part of the model and effects equal to the betas from the mixed regression model. 
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Table 3: Outcomes as adjusted means (SE) at baseline, pre-treatment, end of intervention and follow-up 
 
 
 
 
 
Baseline 
(Start of wait 
weeks) 
 
Pre-treatment 
(End of wait weeks) 
 
  End of Intervention 
 
 
 
   Follow-Up 
 Adjusted mean 
(SE) 
Adjusted mean (SE) Adjusted 
mean (SE) 
Difference from pre-
treatment  (SE, p-
value) 
 
Effect 
Size 
 
Adjusted 
mean (SE) 
Difference from pre-
treatment  (SE, p-
value) 
 
Effect Size 
 
 
PSYRATS (Hall) 
 
 
31.3 (1.10) 
 
 
29.5 (0.93) 
 
26.8 (3.03) 
 
-2.7(3.08, p=0.39) 
 
0.76 
 
23.9 (3.55) 
 
-5.6 (3.89,p= 0.17) 
 
1.57 
 
 
BAVQr 
   Malevolence 
 
 
9.9 (1.24) 
 
 
10.1 (1.08) 
 
 
8.2 (1.30) 
 
 
-1.9 (1.14, p=0.12) 
 
 
0.46 
 
 
8.2 (1.38) 
 
 
-1.9 (1.19, p=0.14) 
 
 
0.45 
    Benevolence 
    Omnipotence 
4.1 (1.30) 
11.5 (0.84) 
3.3 (1.05) 
11.1 (0.79) 
4.3 (1.24) 
10.1 (1.02) 
1.0 (1.33, p=0.45) 
-0.9 (0.79, p=0.26) 
0.25 
0.31 
3.6 (0.95) 
8.7 (0.99) 
0.3 (1.14, p=0.79) 
-2.4  (0.86, p=0.02) 
0.08 
0.78 
             
 
DAIMON 
   Person Addresses Voices 
   Voice Addresses Person 
 
 
 
8.6 (2.51) 
12.1 (2.32) 
 
 
10.5 (2.81) 
15.0 (2.89) 
 
 
11.2 (3.20) 
15.5 (2.41) 
 
 
0.7 (2.55, p=0.79) 
0.5 (2.92, p=0.88) 
 
 
0.06 
-0.04 
 
 
8.1 (1.99) 
11.0 (2.13) 
 
 
-2.4 (2.47, p=0.35) 
-4.0 (3.20, p=0.23) 
 
 
-0.22 
0.36 
         
Self-Compassion Scale  
 
2.3 (0.17) 2.2 (0.18) 2.4 (0.21) 0.2 (0.17, p=0.21) 0.33 2.6 (0.16) 0.4 (0.14, p=0.02) 0.55 
 
DES-Taxon 
 
 
269.0 (54.81) 
 
 
248.7 (52.97) 
 
255.8 
(57.81) 
 
7.1 (19.92, p=0.73) 
 
-0.03 
 
235.9 (57.40) 
 
-12.8 (27.57, p=0.65) 
 
0.06 
 
GAD7 
 
 
16.1 (1.16) 
 
14.1 (1.59) 
 
14.4 (1.42) 
 
0.3 (1.05, p=0.81) 
 
-0.04 
 
12.3 (1.53) 
 
-1.8 (2.36, p=0.46) 
 
0.29 
 
PHQ 
 
 
17.0 (1.85) 
 
17.4 (1.84) 
 
17.2 (2.27) 
 
-0.2 (1.47, p=0.91) 
 
0.03 
 
16.4 (1.83) 
 
-1.0 (1.33 ,p=0.49) 
 
0.13 
 
WEMWBS 
 
32.5 (2.18) 
 
31.3 (2.22) 
 
30.4 (2.97) 
 
-0.9 (2.53, p=0.73) 
 
-0.10 
 
32.9 (2.30) 
 
1.7 (1.71, p=0.35) 
 
0.20 
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Effect size is calculated using the adjusted difference divided by the control s.d. (pre-treatment) and adjusted for each measure such that a positive value represents an 
improvement. 
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